Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ADMA BIOLOGICS, INC. (ADMA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ADMA BIOLOGICS, INC. (ADMA), most recent 12 months reported: revenue $512.27M, net income $168.96M, free cash flow $116.47M. Latest balance sheet on file: liquid cash $136.02M, total debt $196.59M, net cash -$60.57M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): BIO-TECHNE Corp · BIOCRYST PHARMACEUTICALS, INC. · REPLIGEN CORP · TARSUS PHARMACEUTICALS, INC. · Krystal Biotech, Inc. · Twist Bioscience Corporation · Immunocore Holdings plc · NOVAVAX INC

Stock screener

Watchlist